Today's Stock Analyst Initiations and New Coverage

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
BZ KANZHUN	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miranda Zhuang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.71 +1.0%	$19.00	Neutral
CORT Corcept Therapeutics	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srikripa Devarakonda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.37 +1.0%	$164.00	Buy
DFTX Definium Therapeutics	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tazeen Ahmad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.97 -0.6%	$75.00	Buy
DUOL Duolingo	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.25 +7.0%		Underweight ➝ Overweight
DUOL Duolingo	Initiated by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.25 +7.0%		Buy
DUOL Duolingo	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.25 +7.0%		Positive
EDIT Editas Medicine	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.84 -0.2%	$6.00	Buy
ELVN Enliven Therapeutics	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.70 +0.3%	$78.00	Overweight
ELVN Enliven Therapeutics	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andy Hsieh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.70 +0.3%		Outperform
FRNM Freenome	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Brennan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.48 +3.7%	$17.00	Buy
Why acquisitions are reshaping the gold mining sector right now (Ad) Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,228.6% for shareholders of companies like G2 Goldfields, Loncor Gold, and Rupert Resources. Analyst Garrett Goggin, CFA, CMT, tracks which small miners hold the grade, cash flow, and assets that attract buyout interest from major producers. One quarter of his tracked portfolio has already been acquired as the gold bull market's M and A phase accelerates. See Garrett Goggin's top three potential gold buyout targets now
GRRR Gorilla Technology Group	Initiated by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Donovan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.35 +2.6%	$44.00	Buy
HGV Hilton Grand Vacations	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.22 -1.6%	$50.00	Neutral
LBG LBG Media	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 34	GBX 50	Buy
LEU Centrus Energy	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$176.52 -4.1%	$207.00	Equal Weight
NUVB Nuvation Bio	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Priyanka Grover Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.71 +3.5%	$13.00	Overweight
RANI Rani Therapeutics	Initiated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andreas Argyrides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.85 +7.2%		Buy
SCTX Scribe Therapeutics	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.44 +24.8%	$37.00	Outperform
SCTX Scribe Therapeutics	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yanan Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.44 +24.8%	$60.00	Overweight
SCTX Scribe Therapeutics	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Debjit Chattopadhyay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.44 +24.8%	$50.00	Buy
SIND Sinda	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Bell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.04 -3.9%	$19.00	Speculative Buy
SSMR Sunshine Silver Mining & Refining	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dalton Baretto Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.64 -2.3%	$20.00	Speculative Buy
TNL Travel + Leisure	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.53 -0.2%	$95.00	Positive
TRAX First Tracks Biotherapeutics	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.30 +1.6%	$83.00	Outperform
VAC Marriott Vacations Worldwide	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$117.31 -1.8%	$110.00	Neutral
WBI WBI	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eli Jossen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.67 -0.3%	$38.00	Overweight
WEAV Weave Communications	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.29 +31.7%	$8.25	Buy
XRX Xerox	Initiated by	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.00 +1.5%	$5.00	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:10 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Initiations

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Initiations

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools